Alan B. Sandler's Net Worth
-$548 Thousand
Who is Alan B. Sandler?
Alan B. Sandler does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Zai Lab Ltd, Mirati Therapeutics, Inc., Elevation Oncology, Inc., and ALX ONCOLOGY HOLDINGS INC.
SEC CIK
Alan B. Sandler's CIK is 0001835966
Past Insider Trading and Trends
2022 was Alan B. Sandler's most active year for acquiring shares with 6 total transactions. Alan B. Sandler's most active month to acquire stocks was the month of March. 2024 was Alan B. Sandler's most active year for disposing of shares, totalling 4 transactions. Alan B. Sandler's most active month to dispose stocks was the month of December. 2023 saw Alan B. Sandler paying a total of $1,824,972.75 for 39,318 shares, this is the most they've acquired in one year. In 2021 Alan B. Sandler cashed out on 2,075 shares for a total of $147,802.25, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Zai Lab Ltd (ZLAB) Snapshot price: $19.85
Head Global Dev., Oncology
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 4
| +3.80% | 1.06K |
—
|
—
| 28.98K |
Apr 1
| |||
Form 4
| -6.92% | -2.08K |
$71.23 | -$147,802.25 | 27.93K |
Dec 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Mirati Therapeutics, Inc. (MRTX) No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -79.86K |
—
|
—
|
0
|
Jan 23
| |||
Form 4
| +27.32% | 17.02K |
$58.75 | $999,983.75 | 79.32K |
Dec 29
| |||
Form 4
| +55.74% | 22.3K |
$37.00 | $824,989.00 | 62.3K |
Aug 9
| |||
Form 4
|
∞
| 40K |
—
|
—
| 40K |
Nov 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Elevation Oncology, Inc. (ELEV) Snapshot price: $0.6896
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ALX ONCOLOGY HOLDINGS INC (ALXO) Snapshot price: $1.91
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |